Handelsavisen
prelaunch
Companies Healthcare 7600.T
76
7600.T Tokyo Stock Exchange Medical Equipment, Supplies & Distribution

7600.T

¥817,00
Open in Charts → Attach watcher ⌖
JPY
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
21,5B JPY
P/E
EV / Rev
Div yield
2,87 %
Op margin
-1,1 %
ROE
-1,9 %
Net margin
-1,8 %
Debt / equity
0,13
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Toshiba provides a range of healthcare services and equipment, including medical imaging systems, diagnostic equipment, and related solutions.

Business. 7600.T is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue primarily through the sale of products, including capital equipment and consumables. Specific details regarding its operating segments, headquarters location, and primary stock exchange listing are not provided in the available data.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-1,9 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 7600.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 7600.T. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    7600.T is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue primarily through the sale of products, including capital equipment and consumables. Specific details regarding its operating segments, headquarters location, and primary stock exchange listing are not provided in the available data.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    Toshiba's capital structure shows a debt-to-equity ratio of 0.13, indicating a relatively low level of leverage compared to industry norms. The company's liquidity position is characterized by a current ratio of 3.29, suggesting strong short-term liquidity. However, the company's free cash flow is negative at -835,278,000 JPY, which may indicate challenges in generating sufficient cash from operations to fund its capital expenditures.

    Profitability metrics reveal a concerning trend, with a return on equity of -1.87% and a return on assets of -1.37%. These figures are below the industry median and suggest that the company is not effectively utilizing its equity and assets to generate profits. The operating margin is also negative, with an operating income of -275,094,000 JPY, further highlighting the company's operational inefficiencies.

    Toshiba's revenue is primarily concentrated in the healthcare services and equipment segment, with no significant geographic diversification disclosed. The company's exposure to a single business line increases its vulnerability to market fluctuations in the healthcare sector. There is no indication of substantial international operations, which may limit its growth potential in emerging markets.

    The company's growth trajectory is mixed, with a slight decline in revenue from the previous year. Analysts estimate a mean revenue of 24,500,000,000 JPY for the current fiscal year, which is slightly below the actual revenue of 25,114,000,000 JPY. This suggests a potential slowdown in revenue growth, which could impact the company's ability to meet its financial obligations and invest in future growth opportunities.

    Risk factors for Toshiba include a negative net cash position after subtracting total debt, which could affect its financial flexibility. The company's liquidity risk is rated as medium, and while dilution risk is currently low, the negative free cash flow and operating income may necessitate additional financing in the future. The company's recent financial performance, including a net loss of 461,798,000 JPY, further underscores the need for careful financial management.

    Recent events, including the company's financial performance and analyst estimates, indicate a challenging operating environment. The company's negative operating and net income, coupled with a negative free cash flow, suggest that it may need to implement cost-cutting measures or seek additional financing to stabilize its financial position. The company's management will need to address these issues to restore investor confidence and improve its financial performance.

    Key takeaways
    • Toshiba's capital structure is relatively low in leverage, but its negative free cash flow indicates operational challenges.
    • The company's profitability metrics are below industry medians, with a negative return on equity and assets.
    • Revenue is concentrated in a single business segment, increasing vulnerability to market fluctuations.
    • Analyst estimates suggest a potential slowdown in revenue growth, which could impact financial stability.
    • The company faces liquidity and dilution risks, necessitating careful financial management.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    ¥817,00
    Market cap
    ¥20.98B
    Enterprise value
    ¥21.08B
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    20.1x
    P / B
    0.8x
    P / Tangible book
    0.8x
    Tangible book
    ¥24.68B
    Net cash
    -¥104.2M
    Current ratio
    3.3
    Debt / equity
    0.1
    ROA
    -1.4%
    ROE
    -1.9%
    Cash conversion
    -227.0%
    CapEx / revenue
    -6.6%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    16,30
    Predicted surprise
    0,00
    Beat probability
    45 %
    Analysts
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-10 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate16,30
    Revenueno estimateno estimate24,5B JPY
    Operating incomeno estimateno estimateno estimate
    Full-year consensus mean (period as reported by source) · consensus in JPY. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data
    EPS surprise
    −207,6 %
    reported vs consensus · miss
    Revenue surprise
    +2,5 %
    reported vs consensus · beat

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-1,1 %Below median
    Net Margin-1,8 %Below median
    ROE-1,9 %Below median
    Capex / Rev-6,6 %Below median
    D/E0,13Above median
    Cash Conv-2,27Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Ev To Operating Cash Flow
      enterprise_value / operating_cash_flow
    • Return On Equity
      net_income / total_equity
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    Source documents
    • 7600.T Market data — financials · 2026-05-27
    • Japan Medical Dynamic Marketing Inc Market data — analyst estimates · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    7600.TCanonical
    Tokyo Stock Exchange · JPY

    Intel & risk

    PredictorBeat prob45 %Surprise0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage